Detecting Alzheimer's and mood disorders through voice analysis
Official title: Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis
Run by Centre Hospitalier Universitaire de Nice · NCT05943834 · Data updated 2026-11-12
This study is testing whether analyzing voice patterns can help detect Alzheimer's and mood disorders without needing invasive tests like spinal taps or scans.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years to 100 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 1 site (Nice) |
| Status | Recruiting |
| Started | July 13, 2023 |
| Main results expected | October 10, 2027 |
| Study ends | October 10, 2027 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT05943834 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 50 and older with a diagnosis of mild cognitive impairment or very mild dementia.
✕Probably not a fit
Patients with significant hearing problems or those under legal protection may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PLATA project aims to develop an algorithm that identifies vocal biomarkers associated with Alzheimer's disease and affective disorders. By analyzing speech patterns collected during routine care, the study will compare these patterns to established biomarkers like amyloid 1-42 and p-Tau found in cerebrospinal fluid. This innovative approach could potentially eliminate the need for invasive procedures such as lumbar punctures and PET scans for early detection of these conditions.
Why it matters
Potential benefit: If successful, this study could provide a non-invasive method for early detection of Alzheimer's disease and mood disorders.
How similar studies have gone: While the approach of using vocal biomarkers is innovative, similar studies have shown promise in identifying cognitive disorders through speech analysis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 50 years * Diagnosis relevant biomarker and neuropsychological data already available * Cognitively healthy to very mild dementia (CDR score max. 0.5) * Sufficient knowledge of the study language to understand study information, non opposition form,and questionnaires * Expression of non opposition Exclusion Criteria: * Hearing problems * Patient protected by law, under guardianship or curator ship, or not able to participate in a clinical study according to the article L.1121-16 of the French Public Health Code
Where it's running
-
CHU de Nice
Nice, France Recruiting
Study contacts
- Principal investigator: Eric ETTORE, MD — Centre Hospitalier Universitaire de Nice
- Study coordinator: Eric ETTORE, MD
- Email: ettore.e@chu-nice.fr
- Phone: 04.92.03.47.70
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive brain stimulation plus computer-based memory training for mild cognitive impairment
This trial will test whether a short course of non-invasive brain stimulation combined with one of two computer-based brain-training programs helps people aged 60–85 with mild cognitive impairment improve memory, thinking, mood, and daily function.
-
Developing and testing the Liver Cirrhosis Cognitive Decline Scale (LiCCoS)
This project will test a short questionnaire called LiCCoS to see if it can spot thinking and everyday mental problems in adults with liver cirrhosis.
-
Carotid artery wall viscosity and memory problems in older adults
This project will test whether the viscous behavior of the carotid artery wall is linked to memory problems in people over 70 with memory complaints, Alzheimer's disease, or vascular dementia.
-
NeuroFirst brain protection for adults having heart bypass surgery
This trial tests whether a bundled anesthesia approach called NeuroFirst can help people aged 60 and older having planned heart surgery with cardiopulmonary bypass avoid silent brain infarcts and thinking or memory problems after surgery.
-
Nutrition-based interventions to prevent cognitive decline
This study is testing if a 6-month nutrition program can help adults at higher risk for dementia keep their thinking skills sharp.
-
Oral midazolam to help deliver care for older adults with neurocognitive disorders who refuse care
This study will try a short-acting oral midazolam to help nurses and caregivers give essential care to older adults with moderate to severe neurocognitive disorders who resist or refuse care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.